Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Company dna sterling ip
no operation time available
338.77
2 offices
active in Legal Services

We have observed 5 EP applications Bernadette Angelina Hambleton has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after January 12, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12730566

DEVICE COMPRISING NANOSTRUCTURES AND METHOD OF MANUFACTURING THEREOF

IPC classification:
H01J 9/02, H01J 1/304
Agent:
Bernadette Angelina Hambleton, Sterling IP
Agent:
Urban Arvid Oskar Lind, AWA
Status:
PATENT GRANTED
EP12761789

NEUTRALISING ANTIBODIES TO THE MAJOR EXOTOXINS TCDA AND TCDB OF CLOSTRIDIUM DIFFICILE

IPC classification:
A61K 39/40, C07K 16/12, A61P 31/04
Applicant:
UCB Biopharma SPRL
Applicant:
UCB Pharma S.A.
Agent:
Bernadette Angelina Hambleton, Sterling IP
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP12780267

DEVICE FOR THE ASEPTIC EXPANSION OF CELLS

IPC classification:
C12M 1/00
Agent:
Bernadette Angelina Hambleton, Sterling IP
Status:
PATENT GRANTED
EP15190901

SINGLE CHAIN FC POLYPEPTIDES

IPC classification:
C07K 16/00
Applicant:
UCB Biopharma SPRL
Agent:
Bernadette Angelina Hambleton, Sterling IP
Agent:
Amanda Jane Blanchard, UCB Celltech
Status:
The patent has been granted
EP18159326

ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN

IPC classification:
C07K 14/705, C12N 15/86, A61K 35/761
Agent:
Bernadette Angelina Hambleton, Sterling IP
Status:
Request for examination was made

Please Sign in to use this feature